Canada issues final rules on classifying products as drugs, devices

03/18/2013 | Clinica (subscription required)

Health Canada has finalized guidelines for classifying therapeutic products as drugs or devices. The guidance sheds light on the considerations for determining whether a product is a medical device or drug, and it aims to promote a standardized and transparent process when deciding the appropriate regulatory pathway. The guidance notes that a product cannot be considered both a device and a drug.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY